Biotech

All Articles

Gene publisher Volume laying off 131 employees

.Just days after gene publisher Volume Biosciences announced unrevealed functional cuts, a more clea...

Repare lays off 25% of staff as biotech standstills preclinical R&ampD

.Repare Therapeutics is giving up an one-fourth of its own labor force as the oncology biotech scale...

J &amp J files for FDA authorization of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually gotten another step towards noticing a gain on its $6.5 billion n...

Gain's phase 1 win leads way to show Parkinson's drug's worth

.Gain Therapeutics has prepared its sights on showing the performance of its Parkinson's illness tre...

Actinogen records brand new stage 2 records to recover clinical depression medication

.Actinogen Medical's hopes-- as well as inventory rate-- have rebounded somewhat from earlier this m...

Pfizer and also Main incorporate Quotient to multibillion-dollar formula

.Front Runner Pioneering as well as Pfizer have incorporated Ratio into their 10-program collaborati...

Bayer pens $547M pact to drive limits of noncoding RNA

.Bayer managers were actually interested to anxiety to Strong this summer months that the German pha...

UK introduces plannings to launch 18 brand-new professional test hubs

.Amid a yearslong scientific trial decrease in the U.K., a brand-new public-private partnership has ...

UPDATE: Genentech telegrams 93 cutbacks in The golden state after sharing plannings to shutter cancer cells immunology analysis device

.Adhering to the news of a huge cutback round in April and also a major restructuring initiative int...

Neurocrine's KarXT rival strikes in period 2-- yet merely at low dosage

.Neurocrine Biosciences has accomplished its own hoped-for profile page in a stage 2 mental illness ...